MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BSX — Boston Scientific Corp.

NYSE

Boston Scientific Corp.

CompareBack to Screener
$42.60
-0.63(-1.46%)
O
43.32
H
43.44
L
41.94
V
18.24M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Boston Scientific Corp. Statistics

Total Valuation

Market Cap$63.65B
Enterprise Value$64.60B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding1.45B
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio47.33
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio23.67
P/TBV Ration/a
P/FCF Ratio3,722.23
P/OCF Ratio1,257.91
PEG Ration/a

Enterprise Valuation

EV / Earnings482.48
EV / Salesn/a
EV / EBITDA409.92
EV / EBIT516.00
EV / FCF3,777.99

Financial Position

Current Ratio1.90
Quick Ration/a
Debt / Equity0.42
Debt / EBITDA6.97
Debt / FCF64.26
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)5.13%
Return on Assets (ROA)3.02%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$2,269
Employee Count59,000
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax-$17.60M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-55.73%
50-Day Moving Average$46.88
200-Day Moving Average$61.73
Relative Strength Index (RSI)30.21
Average Volume (20 Days)21,309,866

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$361.30M
Operating Income$107.20M
Pretax Income$116.20M
Net Income$133.90M
EBITDA$157.60M
EBIT$125.20M
Earnings Per Share$0.90

Balance Sheet

Cash & Cash Equivalents$145.30M
Total Debt$1.10B
Net Cash-$953.50M
Net Cash Per Share$-0.66
Equity (Book Value)$2.61B
Book Value Per Share$1.80
Working Capital$411.30M

Cash Flow

Operating Cash Flow$50.60M
Capital Expenditures-$17.70M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$17.10M
FCF Per Share$0.01

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield2.11%
FCF Yield0.03%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$13.50
Lynch Upside-68.31%
Graham Number$6.04
Graham Upside-85.82%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a